• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS SARS-COV-2 & INFLUENZA A/B TEST FOR USE ON THE COBAS LIAT SYSTEM; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS SARS-COV-2 & INFLUENZA A/B TEST FOR USE ON THE COBAS LIAT SYSTEM; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID Back to Search Results
Catalog Number 09211101190
Device Problems False Positive Result (1227); Gas Output Problem (1266); Incorrect, Inadequate or Imprecise Result or Readings (1535); Output Problem (3005)
Patient Problems Anxiety (2328); Respiratory Tract Infection (2420); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/27/2021
Event Type  malfunction  
Manufacturer Narrative
(b)(6).A customer from (b)(6) questioned results for 6 patients while using the cobas® sars-cov-2 & influenza a/b nucleic acid test across two cobas® liat® systems.No harm was alleged.An investigation has been initiated and is ongoing.(b)(4).
 
Event Description
In light of the covid-19 pandemic and the subsequent emergency use authorizations (euas) for sars-cov-2 diagnostic tests, the agency has requested heightened reporting beyond the reasonably suggests requirements of 803 to include allegations of false positive or false negative results independent of harm or malfunction or off-label use.Pursuant to the agency¿s instruction, we hereby submit this mdr.A customer from denmark questioned results for several patients while using the cobas® sars-cov-2 & influenza a/b nucleic acid test across two cobas® liat® systems.No harm was alleged.A total of 6 patients were affected, accordingly 6 mdrs will be filed per fda guidance.Originally, the customer questioned discrepant results on analyzer (b)(4) which affected 2 patients.Patient 1 initially generated a positive sars-cov-2 result but was later negative when two new samples were collected and tested on the same platform.Patient 2 was positive for sars-cov-2 a total of 3 times each with new samples across two analyzers but negative with additional repeat testing.The customer also questioned positive sars-cov-2 results for 4 more patients on analyzer (b)(4).According to the customer, several of patients were retested and generated negative results.However, there is no available information to identify which patients received additional testing.An investigation has been initiated and is ongoing.
 
Manufacturer Narrative
Roche has received an increased number of complaints from customers when using cobas® sars-cov-2 & influenza a/b test for use on the cobas® liat® system, lot 10119z.Customers are alleging an increased number of initial positive sars-cov-2 results that were negative upon retests on the same platform and/or on other platforms.Investigative testing using returned kits from the field generated an unexpected sars-cov-2 positive rate of 7% with known negative samples.Considering the involved hazards of the issue, there is a remote probability that use of the affected reagent lot will lead to adverse events in populations at greatest risk for infectious complications due to false positive sars-cov-2 results.Adverse health consequences are otherwise not likely.Consignees have been notified to immediately discontinue the use of and discard any remaining inventory of the cobas® sars-cov-2 & influenza a/b test for use on the cobas® liat® system, lot 10119z.Corrected device code from non-reproducible results to false positive result.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS SARS-COV-2 & INFLUENZA A/B TEST FOR USE ON THE COBAS LIAT SYSTEM
Type of Device
REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
MDR Report Key12095891
MDR Text Key281008296
Report Number2243471-2021-02234
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
PMA/PMN Number
EUA201779
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Remedial Action Notification
Type of Report Initial,Followup
Report Date 08/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2021
Device Catalogue Number09211101190
Device Lot Number10119Z
Date Manufacturer Received07/28/2021
Is This a Reprocessed and Reused Single-Use Device? Yes
Removal/Correction Number2243471-07-28-2021-002-C
Patient Sequence Number1
-
-